- Home
- CTO vs BVS Comparison
CTO vs BVS Comparison
Compare CTO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTO
- BVS
- Stock Information
- Founded
- CTO 1902
- BVS 2011
- Country
- CTO United States
- BVS United States
- Employees
- CTO N/A
- BVS N/A
- Industry
- CTO Real Estate Investment Trusts
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CTO Real Estate
- BVS Health Care
- Exchange
- CTO Nasdaq
- BVS Nasdaq
- Market Cap
- CTO 552.9M
- BVS 476.3M
- IPO Year
- CTO N/A
- BVS 2021
- Fundamental
- Price
- CTO $17.94
- BVS $7.76
- Analyst Decision
- CTO Strong Buy
- BVS Buy
- Analyst Count
- CTO 3
- BVS 3
- Target Price
- CTO $22.00
- BVS $13.33
- AVG Volume (30 Days)
- CTO 268.8K
- BVS 391.5K
- Earning Date
- CTO 10-28-2025
- BVS 11-04-2025
- Dividend Yield
- CTO 8.47%
- BVS N/A
- EPS Growth
- CTO N/A
- BVS N/A
- EPS
- CTO N/A
- BVS 0.15
- Revenue
- CTO $146,948,000.00
- BVS $563,829,000.00
- Revenue This Year
- CTO $20.84
- BVS N/A
- Revenue Next Year
- CTO $6.72
- BVS $7.22
- P/E Ratio
- CTO N/A
- BVS $50.01
- Revenue Growth
- CTO 23.84
- BVS 1.58
- 52 Week Low
- CTO $15.07
- BVS $5.81
- 52 Week High
- CTO $20.88
- BVS $12.61
- Technical
- Relative Strength Index (RSI)
- CTO 69.96
- BVS 61.19
- Support Level
- CTO $17.02
- BVS $6.47
- Resistance Level
- CTO $17.55
- BVS $7.15
- Average True Range (ATR)
- CTO 0.29
- BVS 0.36
- MACD
- CTO 0.03
- BVS 0.01
- Stochastic Oscillator
- CTO 91.03
- BVS 100.00
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.